Underrepresentation of Older Adults in Clinical Trials of Chimeric Antigen Receptor (CAR) T-Cell Therapy for Hematologic Malignancies: An FDA Analysis

被引：0

作者：

Seam, Pamela ^{[1
]}

Mahat, Upendra ^{[2
]}

Bouchkouj, Najat ^{[2
]}

Sharma, Poornima ^{[2
]}

Peredo-Pinto, Helka ^{[2
]}

Elmacken, Mona ^{[2
]}

Kaushal, Megha ^{[2
]}

Jia, Yuxia ^{[2
]}

Wang, Shu ^{[3
]}

Xu, Zhiheng ^{[3
]}

Kasamon, Yvette ^{[1
]}

Kanaparu, Bindu ^{[1
]}

Richardson, Nicholas ^{[1
]}

Gormley, Nicole ^{[1
]}

机构：

[1] US FDA, Div Hematol Malignancies 2, Ctr Drug Evaluat & Res CDER, Silver Spring, MD USA

[2] US FDA, Div Clin Evaluat Hematol, Ctr Biol Evaluat & Res CBER, Off Therapeut Prod OTP, Silver Spring, MD USA

[3] US FDA, Ctr Drug Evaluat & Res CDER, Off Biostat, Silver Spring, MD USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-186544

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[21] Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in hematologic malignancies: a living systematic review on comparative studies
Saiz, Luis Carlos
Leache, Leire
Gutierrez-Valencia, Marta
Erviti, Juan
Reyes, Maria Ximena Rojas
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2023, 14
[22] At The Bedside: Clinical review of chimeric antigen receptor (CAR) T cell therapy for B cell malignancies
Oluwole, Olalekan O.
Davila, Marco L.
JOURNAL OF LEUKOCYTE BIOLOGY, 2016, 100 (06) : 1265 - 1272
[23] Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance
Boyiadzis, Michael M.
Dhodapkar, Madhav V.
Brentjens, Renier J.
Kochenderfer, James N.
Neelapu, Sattva S.
Maus, Marcela V.
Porter, David L.
Maloney, David G.
Grupp, Stephan A.
Mackall, Crystal L.
June, Carl H.
Bishop, Michael R.
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
[24] Chimeric antigen receptor T cell treatment in hematologic malignancies
Goker, Hakan
Malkan, Umit Yavuz
Demiroglu, Haluk
Buyukasik, Yahya
TRANSFUSION AND APHERESIS SCIENCE, 2016, 54 (01) : 35 - 40
[25] Chimeric antigen receptor therapy in hematologic malignancies
Brownlee, Elizabeth
Turley, Melissa
Nations, Heather
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2025, 38 (02): : 17 - 24
[26] Chimeric antigen receptor T cells (CAR-T) for the treatment of T-cell malignancies
Cooper, Mathew L.
DiPersio, John F.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (04)
[27] Chimeric antigen receptor T-cell therapy in hematopoietic and nonhematopoietic malignancies
Ahmad, Faizan
BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL, 2020, 4 (03): : 179 - 185
[28] OPTIMISING CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR HAEMATOLOGICAL MALIGNANCIES
Bahashwan, A.
Kalaitsidou, M.
Schutt, A.
Gilham, D.
Hawkins, R.
HUMAN GENE THERAPY, 2018, 29 (11) : A16 - A16
[29] Chimeric Antigen Receptor (CAR) T-cell Therapy in Neurological Disorders
Habib, Ali
Ciurea, Stefan
Kamboh, Hafsa
Miljkovic, Milos
Mozaffar, Tahseen
NEUROLOGY, 2024, 103 (07) : S119 - S120
[30] Chimeric antigen receptor (CAR) T-cell therapy for multiple myeloma
Choi, Taewoong
Kang, Yubin
PHARMACOLOGY & THERAPEUTICS, 2022, 232

← 1 2 3 4 5 →